Sign In
Buy ACCD
$7.02
+0 (+0%)
At Close: Jul 07, 2025
Accolade to Participate in William Blair Healthcare 2021 Focus List Event
05:00am, Thursday, 17'th Dec 2020
SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
08:00am, Friday, 20'th Nov 2020
SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
Accolade to Participate in the 29th Annual Credit Suisse Healthcare Conference
08:30am, Wednesday, 28'th Oct 2020
SEATTLE, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
Accolade: Still Very Interesting
09:14am, Monday, 17'th Aug 2020
Accolade has seen a solid first quarter since it went public. The company is expecting a softer second quarter, yet sees a growth acceleration in the quarters to follow.
Accolade, Inc. 2021 Q1 - Results - Earnings Call Presentation
10:57am, Friday, 14'th Aug 2020
The following slide deck was published by Accolade, Inc. in conjunction with their 2021 Q1 earnings call..
Accolade's (ACCD) CEO Rajeev Singh on Q1 2021 Results - Earnings Call Transcript
11:14pm, Thursday, 13'th Aug 2020
Accolade, Inc. (NASDAQ:ACCD) Q1 2021 Earnings Conference Call August 13, 2020 5:00 PM ET Company Participants Rajeev Singh – Chief Executive Officer Steve Barnes – Chief Financial Officer Conferen
Accolade Announces Results for Fiscal First Quarter 2021
08:03pm, Thursday, 13'th Aug 2020
* Fiscal first quarter 2021 revenue of $35.9 million, a 25% increase compared to fiscal first quarter 2020 revenue of $28.8 million, driven primarily by strength in new customer adds across segments a
A Significant Market Shift To Value Stocks Is Bound To Happen
01:48pm, Monday, 27'th Jul 2020
A major shift into tech/growth stocks occurred due to the COVID-19 pandemic with the Nasdaq being up 18% YTD. I anticipate that this trend will reverse soon.
Accolade to Announce Fiscal First Quarter 2021 Financial Results
01:00pm, Monday, 27'th Jul 2020
SEATTLE, July 27, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health
U.S. IPO Week Ahead: Tax Software Leads A Diverse 7-IPO Week
08:52am, Saturday, 25'th Jul 2020
Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex.
Mednax, Accolade See Activist Actions
01:04am, Saturday, 18'th Jul 2020
Starboard Value increased its position in pediatric and neonatal health-services firm Mednax. Carrick Management Partners disclosed an initial investment of 3,508,278 shares in Accolade, a newly publi
Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, t
Accolade - Interesting Tech And Healthcare Offering
03:47am, Sunday, 05'th Jul 2020
Accolade operates at the intersection of tech and healthcare, an interesting environment to operate in. I see the potential for the business as the company has
U.S. IPO Weekly Recap: 3 IPOs Close Out The 2Q In Shortened Holiday Week
02:28pm, Friday, 03'rd Jul 2020
Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's billion-dollar deal. All three IPOs upsized their deals and priced above the range. Lem
Accolade Announces Pricing of Initial Public Offering
03:03am, Thursday, 02'nd Jul 2020
Accolade, Inc. ("Accolade"), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, tod
